Mitosol 0.2 MG kits
Ended Awarded
- Contract number
- SPE2DB25FZL09
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,263
Award facts
- Contract value 100% obligated
- $5,263.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
On September 11, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $5,263.24 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mitosol 0.2 mg kits. This firm fixed-price delivery order, with an ultimate completion date of October 2, 2025, was issued without a set-aside designation. The award represents a continuation of DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain, leveraging its extensive contract portfolio with the DLA.
This delivery order is issued under DMS Pharmaceutical Group's broader Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which carries a total potential value of $499,999,999 and extends through November 2026. The IDC enables the DLA to procure a comprehensive range of pharmaceutical products, including prescription medications, biologics, and medical consumables, to support the medical supply needs of military healthcare facilities worldwide. Mitosol, an ophthalmologic medication, aligns with the company's established distribution capabilities for specialized pharmaceutical products serving Department of Defense healthcare sites.
Quick answers
Who was awarded contract SPE2DB25FZL09?
SPE2DB25FZL09 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 11, 2025.
How much is contract SPE2DB25FZL09 worth?
The government has obligated $5,263 on SPE2DB25FZL09.
Is contract SPE2DB25FZL09 an order under another contract?
Yes. SPE2DB25FZL09 is a delivery order under SPE2DB20D9329, an indefinite delivery contract.
Was contract SPE2DB25FZL09 competed?
The extent of competition for SPE2DB25FZL09 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award